Impact Biomedical IBO
NYSE IBO
$3.80 -0.31 (-7.54%)
At close: Oct 22, 2026 · 4:00 PM EDT

Impact Biomedical (IBO) EBIT (2022 - 2026)

Updated

Impact Biomedical (IBO) reported EBIT of -$702,000 for Q2 2026, compared with -$1.15 million a year earlier.

Analysis

Impact Biomedical (IBO) EBIT (2022 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Impact Biomedical's EBIT came in at -$5.09 million; for FY2024, it was -$28.75 million.

  • By year, EBIT came in at -$4.03 million in FY2023 and -$3.4 million in FY2022.
  • The Q2 2026 figure ranks as the highest quarterly EBIT since Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 11.75 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 6.18 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 6.43 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -584.00 Mn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 4.75 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 3.16 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 3.51 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -10.39 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 4.27 Bn
10 Impact Biomedical 409.72 Mn 412.92 Mn 2,000.00 -702,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -702,000.00
Mar 31, 2026 -2.29 Mn
Sep 30, 2025 -948,000.00
Jun 30, 2025 -1.15 Mn
Mar 31, 2025 -1.01 Mn
Dec 31, 2024 -26.23 Mn
Sep 30, 2024 -1.13 Mn
Jun 30, 2024 -626,000.00
Mar 31, 2024 -771,000.00
Dec 31, 2023 -1.14 Mn
Sep 30, 2023 -1.08 Mn
Jun 30, 2023 -1.01 Mn
Mar 31, 2023 -803,000.00
Dec 31, 2022 -1.03 Mn
Sep 30, 2022 -889,000.00
Jun 30, 2022 -750,000.00
API Access

Impact Biomedical EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=IBO&period=max&api_key=YOUR_API_KEY